Focusing on Overseas Markets and Deepening Cost Reduction and Efficiency Enhancement—Yinuorui’s Annual Awards Ceremony Held Successfully

On February 1, 2024, the annual recognition conference of Hubei Enoray Biopharmaceutical Co., Ltd., themed "Pooling Strength for Overseas Markets, Deepening Efforts to Reduce Costs and Enhance Efficiency," was grandly held at the Tianxia Chan Hotel in Xiaochi Town, Huangmei. Sun Wu, Vice President of Hongri Pharmaceutical; Long Huanming, Vice President and Chairman of Enoray; and Kong Kai, General Manager of Enoray, attended the conference. More than 200 employees from Enoray participated in this grand event.

The meeting began with General Manager Kong Kai delivering a summary of 2023 and outlining the 2024 work plan. Mr. Kong reviewed the market environment, 2023 business performance, areas for improvement, and the 2024 work strategy, clearly defining the strategic roadmap for 2024. Mr. Kong emphasized that, guided by Hongri Pharmaceutical’s strategic direction, the company should closely align with its 2024 business plan, pool core strengths to expand into overseas markets and achieve steady growth in overseas market share, and remain steadfastly committed to deepening efforts in cost reduction and efficiency enhancement. To this end, the company will comprehensively tap into its internal potential from multiple angles—including supply chain optimization, reengineering of production processes, and application of technological innovation—striving to reduce operational costs and boost overall economic benefits through refined management and highly efficient operations.

Long Huanming, Vice President of Hongri Pharmaceutical and Chairman of Yinuorui, delivered a New Year’s address, congratulating all employees of Yinuorui on their hard work and achievements in 2023. He pointed out: “Although we’ve achieved some successes in 2023, 2024 will be a pivotal year for the company’s development. We must continue to deepen our technological R&D, enhance product quality, optimize production processes, and further strengthen our market competitiveness.”

The award ceremony honored the outstanding teams and individuals of 2023, aiming to inspire all employees to strive relentlessly and jointly create new brilliance.

With a hundred boats racing across the waters, those who row vigorously will take the lead! Standing at the new starting point of 2024, YinoRui, guided by Hongri Pharmaceutical’s strategic vision, will set forth with high spirits, hoist our sails, and embark on a new journey to create even greater achievements!